Your browser doesn't support javascript.
loading
MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer.
Yang, Yang; Wu, Nandie; Shen, Jie; Teixido, Cristina; Sun, Xia; Lin, Zihan; Qian, Xiaoping; Zou, Zhengyun; Guan, Wenxian; Yu, Lixia; Rosell, Rafael; Liu, Baorui; Wei, Jia.
Afiliación
  • Yang Y; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.
  • Wu N; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.
  • Shen J; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.
  • Teixido C; Pangaea Biotech, USP Dexeus University Institute, Barcelona, Spain.
  • Sun X; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.
  • Lin Z; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.
  • Qian X; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.
  • Zou Z; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.
  • Guan W; Department of General Surgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
  • Yu L; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.
  • Rosell R; Pangaea Biotech, USP Dexeus University Institute, Barcelona, Spain.
  • Liu B; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Medical Oncology Service, Badalona, Spain.
  • Wei J; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, 321 Zhongshan Road, Nanjing, 210008, China.
Gastric Cancer ; 19(3): 778-88, 2016 Jul.
Article en En | MEDLINE | ID: mdl-26404902
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Piridinas / Neoplasias Gástricas / Biomarcadores de Tumor / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-met / Inhibidores de Proteínas Quinasas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Piridinas / Neoplasias Gástricas / Biomarcadores de Tumor / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-met / Inhibidores de Proteínas Quinasas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: China